Harvard Bioscience (HBIO) Net Cash Flow Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -63.96% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -55.30% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 126.35% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -159.29% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 78.59% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 36.49% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 45.74% |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | -17.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.64% |
| Dec 31, 2025 | 101.10% |
| Sep 30, 2025 | -43.06% |
| Jun 30, 2025 | 44.94% |
| Mar 31, 2025 | 35.09% |
| Dec 31, 2024 | -26.86% |
| Sep 30, 2024 | 30.67% |
| Jun 30, 2024 | -36.98% |
| Mar 31, 2024 | 27.06% |
| Dec 31, 2023 | -29.23% |
| Sep 30, 2023 | 147.30% |
| Jun 30, 2023 | 29.50% |
| Mar 31, 2023 | 31.26% |
| Dec 31, 2022 | -30.34% |
| Sep 30, 2022 | -35.13% |
| Jun 30, 2022 | -107.21% |
| Mar 31, 2022 | 9.10% |
| Dec 31, 2021 | 13.44% |
| Sep 30, 2021 | -38.31% |
| Jun 30, 2021 | 191.10% |